Biogen & TheraPanacea Announce New Collaboration with the Potential to Advance Digital Health for Personalized Medicine in Neuroscience
December 14, 2021 - 13:00 CET The aim is to develop…
FDA (510k) clearance for ART-Plan™
TheraPanacea receives FDA (510K) clearance for ART-Plan™:…
TheraPanacea & Egyptian Ministry of Communications and Information Technology
TheraPanacea & Egypt
TheraPanacea, Gustave Roussy, AP-HP, ICANS | Institut de cancérologie Strasbourg Europe and GE Healthcare target to improve brain tumor survival through AI-based personalized radiation treatment
Improve brain tumor survival through AI-based personalized…
New collaborative data bank key to develop AI-based tools for Covid-19 diagnostic and treatment
AI-based tools for Covid-19 diagnostic and treatment
Predicting the response to immunotherapy with artificial intelligence
Immunotherapy with AI